Id: CBI_2984 | Pages: 250 | Format : PDF | Last Updated : | Author : Amit Sati | Category : Materials And Chemicals
Ursolic Acid Market size is growing with a CAGR of 6.4% during the forecast period (2025-2032), and the market is projected to be valued at USD 208.34 Million by 2032 from USD 127.50 Million in 2024. Additionally, the market value for the 2025 attributes to USD 135.18 Million.
Ursolic acid (UA) is a naturally occurring pentacyclic triterpenoid compound. It is found in various plants such as herbs like rosemary, basil, and thyme, as well as fruits like apples, cranberries, and grapes. It has received significant attention for its diverse range of biological activities. It demonstrates promising properties as an anti-inflammatory, antioxidant, anticancer, and cardioprotective agent. The purity of this acid varies, ranging from below 50% to over 90%, influencing its potency and suitability for different applications. The primary end-use sectors include personal care and cosmetics, where it is used for its anti-aging and skin-soothing effects. In food and beverage, it has potential as a functional ingredient. In nutraceuticals, it is used in dietary supplements for its health benefits. In pharmaceuticals, it is used for its therapeutic potential in various diseases. Ongoing research continues to explore and validate its wide-ranging applications.
Ursolic acid has the ability to stimulate collagen production, provide potent antioxidant and anti-inflammatory effects, and enhance skin barrier function. It has become a lucrative ingredient for formulations targeting wrinkles, elasticity, and overall skin rejuvenation. Additionally, the need for innovative formulations in cosmetics is driving its manufacturers to incorporate UA into a diverse range of products.
For instance,
Thus, due to the aforementioned factors, the increasing cosmetic manufacturing is accelerating the ursolic acid market expansion.
There is increasing consumer awareness of the drawbacks associated with synthetic ingredients, leading to a growing preference for natural products. Additionally, consumers are inclined towards plant-based alternatives due to the perception of them being more natural, healthier, and often associated with fewer side effects compared to animal-derived options. UA is a naturally occurring compound with demonstrated health benefits, creating its high utilization in industries such as pharmaceuticals and nutraceuticals amongst others. Consumers seeking natural products is driving the need for UA in different industries.
For instance,
Thus, the rising focus on natural ingredients is accelerating the global ursolic acid market growth.
The lack of balanced global regulations and robust standardization presents significant hurdles. The absence of universally accepted quality standards and testing methodologies across different regions creates inconsistencies in product quality and hinders seamless international trade. Varying regulatory frameworks for dietary supplements and pharmaceuticals in different countries lead to complex and time-consuming approval processes for ursolic acid-based products. This lack of harmonization increases compliance costs for manufacturers seeking global market access. Furthermore, concerns regarding the purity, source, and potential adulteration of UA extracts erode consumer trust and impede the market. Hence, the regulatory hurdles and standardization are hampering the ursolic acid market demand.
The utilization of ursolic acid in oncology lies in the growing emphasis on inclusive anti-cancer research. The participation of diverse populations in preclinical and clinical studies has helped to gain a more comprehensive understanding of UA's efficacy and safety across various demographic and genetic backgrounds, potentially revealing targeted benefits for specific patient subgroups. This approach not only addresses health disparities but also expands the pool of potential patients and drives personalized medicine strategies amongst others creating the potential for the market adoption of UA-based anticancer therapies.
For instance,
Thus, the inclusion of UA in anti-cancer research is expected to increase ursolic acid market opportunities.
Based on purity, the market is categorized into upto 50%, 51% to 90%, and above 90%.
Trends in Purity:
The 51% to 90% segment accounted for the largest market share in 2024.
The above 90% segment is expected to grow at the fastest CAGR over the forecast period.
Based on source, the market is categorized into herbs, fruits, and others.
Trends in Source:
The herbs segment accounted for the largest market share in 2024 and is expected to grow at the fastest CAGR over the forecast period.
Based on end-use, the market is categorized into personal care & cosmetics, food & beverage, nutraceuticals, pharmaceuticals, and others.
Trends in the End-Use
The personal care & cosmetics segment accounted for the largest market share of 47.81% in 2024.
The nutraceuticals segment is expected to grow at the fastest CAGR over the forecast period.
The regional segment includes North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.
In 2024, Asia Pacific accounted for the highest ursolic acid market share at 41.85% and was valued at USD 53.35 Million and is expected to reach USD 81.65 Million in 2032. In Asia Pacific, the China accounted for the ursolic acid market share of 38.12% during the base year of 2024. The rising demand for natural products in the MEA is also creating a market for Ursolic Acid as a dietary supplement. Consumers seeking natural support for overall well-being, including potential benefits related to inflammation management, metabolic health, and even muscle health, are drawn to UA-based supplements. As awareness of its diverse potential health benefits grows within the region, the nutraceutical market also expands.
For instance,
Thus, due to the aforementioned factors, Asia Pacific is expected to dominate the market in 2024
In Europe, the ursolic acid market is experiencing the fastest growth with a CAGR of 7.3% over the forecast period. Improved and more efficient methods are making UA production more cost-effective and sustainable, facilitating greater access to this compound for research purposes. This enhanced availability encourages further investigation into its potential anti-cancer properties and the development of novel therapies. As extraction becomes more scalable and economical, it supports the growing interest in exploring UA’s therapeutic applications in oncology across the European pharmaceutical landscape.
North America ursolic acid market analysis indicates that several key trends are contributing to its growth in the region. Ongoing scientific investigations are continuously unveiling new potential health benefits, expanding its applications beyond traditional uses. Simultaneously, the growing exploration of UA as a natural preservative and health-enhancing ingredient within the food and beverage sector is creating new market potential and further fueling its need across the region. The growing preference for plant-derived ingredients in various industries, including nutraceuticals favors UA extracted from herbs and fruits.
The increasing requirements for natural products across the cosmetics sector in the Middle East and Africa (MEA) creates potential for the market. As consumers become more conscious about personal grooming and well-being, the need for natural and effective ingredients in skincare, haircare, and other beauty products rises. UA is recognized as an antioxidant, making it an appealing component for manufacturers catering to this growing consumer base seeking natural formulations. This trend, coupled with rising disposable incomes, further supports the market in the region.
The Latin America market presents a lucrative opportunity for the market. The rising prevalence of chronic diseases, including inflammation, diabetes, and cardiovascular issues, is a significant driver for ursolic acid's adoption in both nutraceuticals and pharmaceuticals due to its potential to manage these conditions. Furthermore, emerging evidence highlighting its positive effects on muscle health and weight management is fueling its increasing use in sports nutrition and dietary supplements aimed at promoting muscle development and fat loss.
The Ursolic Acid market is highly competitive with major players providing products to the national and international markets. Key players are adopting several strategies in research and development (R&D) and product innovation to hold a strong position in the global Ursolic Acid market. Key players in The Ursolic Acid industry include-
Report Attributes | Report Details |
Study Timeline | 2019-2032 |
Market Size in 2032 | USD 208.34 Million |
CAGR (2025-2032) | 6.4% |
By Purity |
|
By Source |
|
By End User |
|
By Region |
|
Key Players |
|
North America | U.S. Canada Mexico |
Europe | U.K. Germany France Spain Italy Russia Benelux Rest of Europe |
APAC | China South Korea Japan India Australia ASEAN Rest of Asia-Pacific |
Middle East and Africa | GCC Turkey South Africa Rest of MEA |
LATAM | Brazil Argentina Chile Rest of LATAM |
Report Coverage |
|
In 2024, the Ursolic Acid market is USD 127.50 Million.
Europe is the fastest-growing region in the Ursolic Acid market.
Purity, Source, and End-Use segmentation details are covered in the Ursolic Acid market.
Merck KGaA (Germany), Cayman Chemical Company (U.S.), Matrix Life Science Pvt. Ltd. (India), Sabinsa Corporation (U.S.), BECARRE Natural (France), and Xi'an Healthful Biotechnology Co., Ltd (China) are some major players in the market.